[Clinical features and prognostic factors in children with fulminant myocarditis]

Liang Pei1, Ni Yang, Yu-Hang Yang

  • 1Department of Pediatric Intensive Care Unit, Shengjing Hospital Affiliated to China Medical University, Shenyang 110004, China. liucf@sj-hospital.org.

Insights

Fulminant myocarditis in children lacks specific symptoms. A reduced left ventricular ejection fraction (LVEF) is a significant risk factor for a poor prognosis in pediatric fulminant myocarditis cases.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Infectious Diseases

Context:

  • Fulminant myocarditis is a severe inflammation of the heart muscle in children.
  • Early identification of prognostic factors is crucial for timely intervention and improved outcomes.
  • This study retrospectively analyzed clinical data of pediatric patients diagnosed with fulminant myocarditis.

Purpose:

  • To investigate the clinical characteristics of fulminant myocarditis in children.
  • To identify clinical features and laboratory markers associated with prognosis.
  • To determine risk factors influencing mortality in pediatric fulminant myocarditis.

Summary:

  • The study analyzed 24 children with fulminant myocarditis, classifying them into survival (n=12) and death (n=12) groups.
  • Initial symptoms varied, including gastrointestinal and neurological presentations. Elevated cardiac biomarkers (CK-MB, Troponin I, BNP) and reduced left ventricular ejection fraction (LVEF) were common.
  • Lower LVEF and higher peak serum BNP levels were observed in the non-survival group. Multivariate analysis identified decreased LVEF as a significant risk factor for poor prognosis (OR=7.418; P<0.05).

Impact:

  • Fulminant myocarditis in children presents with diverse, non-specific clinical features.
  • A decreased left ventricular ejection fraction (LVEF) is a critical indicator of poor prognosis in pediatric fulminant myocarditis.
  • Findings aid in risk stratification and management strategies for children with this life-threatening condition.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
319
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
568
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
354
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
775